Evidence map›Paper›PMID 30989646›Full record

ArticleJournal of cellular physiology2019

Hypoxic regulation of angiotensin-converting enzyme 2 and Mas receptor in human CD34

Shrinidh Joshi, Hannah Wollenzien, Estelle Leclerc, Yagna Pr Jarajapu

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH.JHEP reports : innovation in hepatology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Circulating angiotensin converting enzyme 2 and COVID-19.World journal of clinical cases · 2022
    Review
  8. The Role of Stem Cells in the Therapy of Stroke.Current neuropharmacology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Impact of Hypoxia over Human Viral Infections and Key Cellular Processes.International journal of molecular sciences · 2021
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shrinidh JoshiDepartment of Pharmaceutical Sciences, College of Health Professions, North Dakota State University, Fargo, North Dakota.
Hannah WollenzienDepartment of Pharmaceutical Sciences, College of Health Professions, North Dakota State University, Fargo, North Dakota.
Estelle LeclercDepartment of Pharmaceutical Sciences, College of Health Professions, North Dakota State University, Fargo, North Dakota.
Yagna Pr JarajapuDepartment of Pharmaceutical Sciences, College of Health Professions, North Dakota State University, Fargo, North Dakota.
North Dakota State University · US

Funding

Pilot Projects: Core DP30GM103332 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI SIBI, MUKUND P. · 2012 to 2016
$4.9M
Targeting Mas Receptor for Diabetic Vascular Disease in Older AdultsR01AG056881 · NIA · NORTH DAKOTA STATE UNIVERSITY · PI Yagna Jarajapu · 2017 to 2026
$3.2M
American Heart Association-American Stroke Association 13SDG16960025NIA NIH HHS R01 AG056881NIGMS NIH HHS P30 GM103332
6 · The paper itself

Abstract

CD34

Indexed as

AdultAgedAngiotensin-Converting Enzyme 2Antigens, CD34FemaleHumansHypoxiaMaleMiddle AgedPeptide FragmentsPeptidyl-Dipeptidase AProto-Oncogene MasProto-Oncogene ProteinsReceptors, G-Protein-CoupledRenin-Angiotensin SystemVascular Endothelial Growth Factor AACE2 protein, humanAce2 protein, mouseAngiotensin-Converting Enzyme 2Antigens, CD34MAS1 protein, humanPeptide FragmentsPeptidyl-Dipeptidase AProto-Oncogene MasProto-Oncogene ProteinsReceptors, G-Protein-CoupledVascular Endothelial Growth Factor AACE2CD34+ cellshypoxiaMas receptor

Identifiers

PMID30989646
PMCPMC6660366
OpenAlexW2905943152

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.